PROTEINE UND VERWENDUNGEN

European patent · EP3529275 · In force

Register entry

Publication number
EP3529275
Application number
EP17794919
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 23, 2017
Published
Aug 28, 2019
Granted
Dec 8, 2021
Protection ends at the latest
Oct 22, 2037
Next annual fee due
Oct 31, 2026
IPC classes
C07K 16/24 (2006.01)
C07K 16/28 (2006.01)
Priority
GB 201617924 24.10.2016
PCT application
PCT/EP2017/076948 23.10.2017
PCT publication
WO2018/077775 03.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Oct 19, 2022

    Change

    Published in Swissreg on 19.10.2022

  6. Dec 8, 2021

    Granted

    Published in Swissreg on 08.12.2021

Parties

Holder

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventor

BURNLEY, Rebecca

Slough Berkshire SL1 3WE, GB

WRIGHT, Michael John

Slough Berkshire SL1 3WE, GB

ETTORRE, Anna

Slough Berkshire SL1 3WE, GB

ADAMS, Ralph

Slough Berkshire SL1 3WE, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.